AIM ImmunoTech Inc’s recently made public that its CEO & President Equels Thomas K acquired Company’s shares for reported $1515.0 on Sep 16 ’24. In the deal valued at $0.30 per share,5,000 shares were bought. As a result of this transaction, Equels Thomas K now holds 1,493,042 shares worth roughly $0.33 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Equels Thomas K bought 20,000 shares, generating $6,160 in total proceeds. Upon buying the shares at $0.31, the CEO & President now owns 1,488,042 shares.
Before that, Equels Thomas K bought 61,729 shares. AIM ImmunoTech Inc shares valued at $25,000 were divested by the CEO & President at a price of $0.41 per share. As a result of the transaction, Equels Thomas K now holds 778,184 shares, worth roughly $0.17 million.
Price Performance Review of AIM
On Friday, AIM ImmunoTech Inc [AMEX:AIM] saw its stock fall -11.75% to $0.22. Over the last five days, the stock has lost -8.61%. AIM ImmunoTech Inc shares have fallen nearly -49.31% since the year began. Nevertheless, the stocks have fallen -52.56% over the past one year. While a 52-week high of $0.62 was reached on 04/11/24, a 52-week low of $0.21 was recorded on 09/20/24. SMA at 50 days reached $0.2657, while 200 days put it at $0.3624.
Levels Of Support And Resistance For AIM Stock
The 24-hour chart illustrates a support level at 0.2121, which if violated will result in even more drops to 0.2011. On the upside, there is a resistance level at 0.2425. A further resistance level may holdings at 0.2619. The Relative Strength Index (RSI) on the 14-day chart is 35.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0092, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.58%. Stochastics %K at 31.33% indicates the stock is a holding.
How much short interest is there in AIM ImmunoTech Inc?
A steep rise in short interest was recorded in AIM ImmunoTech Inc stocks on 2024-10-31, dropping by 98955.0 shares to a total of 0.49 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.59 million shares. There was a decline of -20.14%, which implies that there is a negative sentiment for the stock.
